期刊文献+

耐碳青霉烯类鲍氏不动杆菌医院获得性肺炎危险因素分析 被引量:13

Risk factors of hospital-acquired pneumonia caused by carbapenem-resistant acinetobacter baumannii
原文传递
导出
摘要 目的探讨耐碳青霉烯类鲍氏不动杆菌(CRAB)医院获得性肺炎的危险因素。方法采用病例对照研究,收集2005年1月-2010年12月鲍氏不动杆菌(ABA)引起的医院获得性肺炎92例,分为CRAB医院获得性肺炎组30例和碳青霉烯类敏感鲍氏不动杆菌(CSAB)医院获得性肺炎组62例;采用单因素分析及多因素logistic回归分析。结果单因素分析发现,APACHEⅡ评分≥16分、气管插管或气管切开、机械通气、分离出ABA前<2周曾应用过亚胺培南或美罗培南、≥2种抗菌药物联合应用与CRAB感染有关;多因素logistic回归分析发现,APACHEⅡ≥16分(OR=4.144,95%Cl1.346~12.761,P=0.013)及分离出CRAB前<2周曾应用过亚胺培南或美罗培南(OR=3.236,95%Cl1.128~9.282,P=0.029)是独立危险因素;CRAB组死亡11例,CSAB组死亡19例,2组死亡率差异无统计学意义。结论 APACHEⅡ≥16分及分离出CRAB前<2周曾应用过亚胺培南或美罗培南,是CRAB医院获得性肺炎的独立危险因素。 OBJECTIVE To study the risk factors of hospital acquired pneumonia (HAP) caused by carbapenem- resistant Acinetobacter baumannii (CRAB). METHODS A retrospective case control study was conducted for the patients who had HAP caused by A. baumannii (ABA) between Jan 2005 and Dec 2010. There were 30 cases of HAP caused by CRAb and 62 cases of HAP caused by CSAB (carbapenem-senstive A. baumannii). Univariate analysis (T test and chi-square test) and multivariate logistic regression were used for statistics analysis. RESULTS Univariate analysis revealed that five factors were associated with the infection caused by CRAB, which were APACHE Ⅱ score ≥16, imipenem/meropenem used less than 2 weeks before isolation of CRAB, and combination therapy of antibiotics, invasive mechanical ventilation, endotracheal intubation/tracheotomy. Multivariate logistic regression analysis identified two independent factors, which were APACHEII score ≥16 (OR= 4. 144) and imipenem/meropenem used less than 2 weeks before isolation of CRAB (OR=3. 236). CONCLUSION APACHE II score ≥16 and imipenem/meropenem used less than 2 weeks before the isolation of CRAB are the independent risk factors for CRAB infection.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2011年第14期2954-2956,共3页 Chinese Journal of Nosocomiology
关键词 鲍氏不动杆菌 医院获得性肺炎 耐碳青霉烯类 危险因素 Acinetobacterbaumannii Hospital-acquired pneumonia Carbapenem-resistant Risk factors
  • 相关文献

参考文献12

  • 1Richet HM. Nosocomial gram-negative bacilli:they are back! Dealing with Acinetobacter[J]. 44th Interscience conference on Antimicrobial Agents and Chemotherapy, October 30-November 2,2004. Washington DC.
  • 2朱会英,王艳,褚亚辉,徐德兴,张海燕.2005-2009年鲍氏不动杆菌检出及耐药率分析[J].中华医院感染学杂志,2010,20(23):3778-3780. 被引量:94
  • 3NNIS System. National Nosocomial Infections SurveiUance (NNIS) system Report, data summary from January 1992 through June 2003,issuedAugust 2003[J]. Am J Infect Control,2003,31(8):481-498.
  • 4医院感染诊断标准(试行)[J].中华医学杂志,2001,81(5):314-320. 被引量:6487
  • 5American Thoracic Society:Infectious Diseases Society of Amerits. Guidelines for the management of adults with hospital-acquired. ventilator-associated and healthcare-associated pneumonia[J]. Am J Respir Crit Care Med,2005,171(4) :388-416.
  • 6Paterson DL. Looking for risk factors for the acquisition of antibiotic resistance:a 21st-century approach[J]. Clin Infect Dis,2002,34(12):1564-1567.
  • 7Routsi C, Pratikaki M. Carbapenem-resistant versus carbap-enem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit. risk factors, clinical features and outcomes[J]. Infection,2010,38(3) :173-180.
  • 8Falagas ME, Kopterides P. Risk factors for the isolation of multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa:a systemic review of the literature[J]. J Hosp Infeet,2006,64(1) :7-15.
  • 9Mentzelopoulos S, Pratikaki M, Platsouka E, et al. Pro- longed use of carbapenems and eolistin predisposes to ventila- tor-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa[J]. Intensive Care Med,2007,33(9):1524-1532.
  • 10Falagas ME, Bliziotis IA, Siempos II. Attributable mortality of Acinetobacter baumannii infections in critically ill patients:a system atic review of matched cohort and case-control studies [J]. CritCare,2006,10(2):R48.

二级参考文献3

  • 1李苏利,李杨,华川.多重耐药鲍氏不动杆菌耐药现状与临床对策[J].中华医院感染学杂志,2005,15(12):1438-1440. 被引量:104
  • 2Lepper PM, Grusa E, Reichl H, et al. Consumption of Imipenem Correlates with β-Lactam Resistance in Pseudomonas aeruginosa [J]. Antimicrob Agents Chemother, 2002, 46: 2920-2925.
  • 3Urban C, Segal-Maurer S, Rahal JJ. Considerations in control and treatment of nosocomial infection due to multidrug-resistant Acinetobacter baumannii [J]. Clin Infect Dis, 2003, 36 (10) : 1268-1274.

共引文献6579

同被引文献134

引证文献13

二级引证文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部